These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3593399)

  • 1. Substituted trifluoroketones as potent, selective inhibitors of mammalian carboxylesterases.
    Ashour MB; Hammock BD
    Biochem Pharmacol; 1987 Jun; 36(12):1869-79. PubMed ID: 3593399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent induction of microsomal carboxylesterase activities in tissues of clofibrate-fed mice and rats.
    Ashour MB; Moody DE; Hammock BD
    Toxicol Appl Pharmacol; 1987 Jul; 89(3):361-9. PubMed ID: 3603566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for substrates and inhibitors of mammalian liver microsomal carboxylesterases.
    Huang TL; Shiotsuki T; Uematsu T; Borhan B; Li QX; Hammock BD
    Pharm Res; 1996 Oct; 13(10):1495-500. PubMed ID: 8899840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of new carboxylesterase inhibitors and evaluation of potency and water solubility.
    Wheelock CE; Severson TF; Hammock BD
    Chem Res Toxicol; 2001 Dec; 14(12):1563-72. PubMed ID: 11743738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal hormone-induced changes in hepatic microsomal carboxylesterase in rats.
    Hosokawa M; Satoh T; Ohkawara S; Ohmori S; Igarashi T; Ueno K; Kitagawa H
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):245-58. PubMed ID: 6515118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors.
    Wheelock CE; Colvin ME; Uemura I; Olmstead MM; Sanborn JR; Nakagawa Y; Jones AD; Hammock BD
    J Med Chem; 2002 Dec; 45(25):5576-93. PubMed ID: 12459025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro deacetylation studies with isomeric acetamidobiphenyls using selective carboxylesterase inhibitors.
    Sertkaya NN; Gorrod JW
    Anticancer Res; 1988; 8(6):1345-50. PubMed ID: 3218967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of carbonates, thiocarbonates, carbamates, and carboxylic esters of alpha-naphthol, beta-naphthol, and p-nitrophenol by human, rat, and mouse liver carboxylesterases.
    Huang TL; Székács A; Uematsu T; Kuwano E; Parkinson A; Hammock BD
    Pharm Res; 1993 May; 10(5):639-48. PubMed ID: 8321828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific and regioselective hydrolysis of cannabinoid esters by ES46.5K, an esterase from mouse hepatic microsomes, and its differences from carboxylesterases of rabbit and porcine liver.
    Watanabe K; Matsunaga T; Kimura T; Funahashi T; Yamaori S; Shoyama Y; Yamamoto I
    Biol Pharm Bull; 2005 Sep; 28(9):1743-7. PubMed ID: 16141551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification and characterization of a microsomal carboxylesterase specific for salicylate esters from guinea-pig liver.
    White KN; Hope DB
    Biochim Biophys Acta; 1984 Mar; 785(3):138-47. PubMed ID: 6704404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isozyme-selective metabolism of ethyl carbamate by cytochrome P450 (CYP2E1) and carboxylesterase (hydrolase A) enzymes in murine liver microsomes.
    Lee RP; Parkinson A; Forkert PG
    Drug Metab Dispos; 1998 Jan; 26(1):60-5. PubMed ID: 9443854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of hepatic carboxylesterases hydrolyzing hydrocortisone esters.
    Ali B; Kaur S; James EC; Parmar SS
    Biochem Pharmacol; 1985 Jun; 34(11):1881-6. PubMed ID: 4004904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of microsomal and cytosolic carboxylesterases in the rat liver by in vivo and in vitro inhibition.
    Nousiainen U; Törrönen R
    Gen Pharmacol; 1984; 15(3):223-7. PubMed ID: 6735136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of aspirin hydrolase of guinea-pig liver cytoplasm.
    White KN; Hope DB
    Biochim Biophys Acta; 1984 Mar; 785(3):132-7. PubMed ID: 6704403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypophysectomy and pituitary hormones on hepatic microsomal carboxylesterase isozymes in male rats.
    Hosokawa M; Satoh T
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):279-88. PubMed ID: 3251337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxylesterase Inhibitors: An Update.
    Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
    Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis.
    Harada T; Nakagawa Y; Wadkins RM; Potter PM; Wheelock CE
    Bioorg Med Chem; 2009 Jan; 17(1):149-64. PubMed ID: 19062296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties and inhibition of rat malathion carboxylesterases.
    Mallipudi NM; Talcott RE; Ketterman A; Fukuto TR
    J Toxicol Environ Health; 1980 May; 6(3):585-96. PubMed ID: 7420466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meperidine carboxylesterase in mouse and human livers.
    Lotti M; Ketterman A; Waskell L; Talcott RE
    Biochem Pharmacol; 1983 Dec; 32(24):3735-8. PubMed ID: 6661249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.